Paul Rodenbiker, FNP-C

Paul Rodenbiker practices at Sanford Fargo Hospice in Fargo, North Dakota.

Paul Rodenbiker's NPI, 1629639919, was assigned on June 26, 2019. Paul Rodenbiker holds North Dakota license R34719.

Paul Rodenbiker's primary practice is Sanford Fargo Hospice, at 801 Broadway North, Fargo, ND 58102 in Cass County. The practice phone is (701) 234-7550.

Paul Rodenbiker's primary practice is Sanford Fargo Hospice in Fargo, North Dakota. Paul Rodenbiker is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford West Fargo Clinic. Dmand AI also links Paul Rodenbiker to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Paul Rodenbiker practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Paul Rodenbiker's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Paul Rodenbiker is licensed in North Dakota.

CMS counts 218 Medicare patients who saw Paul Rodenbiker in 2024. The largest group is under 65, with 84 patients. 61% of them have high cholesterol, and 54% have high blood pressure. 38% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Paul Rodenbiker's median patient age at 65, with 64% women.

In 2024, Paul Rodenbiker wrote 2,872 Medicare Part D claims for 284 patients. 89% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Paul Rodenbiker for performance year 2024, reported as part of a group. Paul Rodenbiker accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Paul Rodenbiker as offering telehealth.

CMS Open Payments shows 5 general payments to Paul Rodenbiker from 4 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $52.